Treatment of scabies: The topical ivermectin vs. permethrin 2.5% cream

• Autorzy: Goldust M. , Rezaee E. , Raghifar R. , Hemayat S.
• Języki publikacji: EN

Abstrakty

EN

Human scabies is caused by an infestation of the skin by the human itch mite (Sarcoptes scabiei var. hominis). It is commonly treated with topical insecticides, but the treatment of choice is still controversial. The aim of this study is to compare the efficacy of topical ivermectin vs. permethrin 2.5% cream for the treatment of scabies. In total, 380 patients with scabies were enrolled, and randomized into two groups: the first group received 1% ivermectin applied topically to the affected skin at a dose of 400 microg/kg, repeated once the following week, while the second group received permethrin 2.5% cream and were told to apply this twice at one week intervals. Treatment was evaluated at intervals of 2 and 4 weeks, and if there was treatment failure at the 2-week follow-up, treatment was repeated. Two applications of topical ivermectin provided a cure rate of 63.1% at the 2-week follow-up, which increased to 84.2% at the 4-week follow-up after repeating the treatment. Treatment with two applications of permethrin 2.5% cream with a 1-week interval between them was effective in 65.8% of patients at the 2-week follow-up, which increased to 89.5% at the 4-week follow-up after this treatment was repeated. Two application of ivermectin was as effective as two applications of permethrin 2.5% cream at the 2-week follow-up. After repeating the treatment, ivermectin was as effective as permethrin 2.5% cream at the 4-week follow up.

Słowa kluczowe

EN

human disease; treatment; scabies; topical ivermectin; permethrin cream; mite; Sarcoptes scabiei

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2013
• Tom: 59
• Numer: 2
• Opis fizyczny: p.79-84,fig.

Twórcy

autor

Goldust M.

• Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

autor

Rezaee E.

• Department of Medicinal Chemistry, Shahid Beheshti University of Medical Sciences, Teheran, Iran

autor

Raghifar R.

• Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

autor

Hemayat S.

• Teheran Azad University of Medical Sciences, Teheran, Iran

Bibliografia

• [1] Goldust M., Rezaee E. 2013. The efficacy of topical ivermectin vs. malation 0.5% lotion for the treatment of scabies. Journal of Dermatological Treatment (in press).
• [2] Lotti T., Goldust M., Rezaee E. 2013. Treatment of seborrheic dermatitis, comparison of sertaconazole 2% cream vs. ketaconazole 2% cream. Journal of Dermatological Treatment (in press).
• [3] Goldust M., Rezaee E., Raghifar R. 2013. Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies. Journal of Toxicology – Cutaneous and Ocular Toxicology (in press).
• [4] Levi A., Mumcuoglu K.Y., Ingber A., Enk C.D. 2011. Assessment of Sarcoptes scabiei viability in vivo by reflectance confocal microscopy. Lasers in Medical Science 26: 291-292.
• [5] Gilmore S.J. 2011. Control strategies for endemic childhood scabies. PLoS One 6: e15990.
• [6] Goldust M., Golforoushan F., Rezaee E. 2011. Treatment of solar lentigines with trichloroacetic acid 40% vs. cryotherapy. European Journal of Dermatology 21: 426-427.
• [7] Goldust M., Ranjkesh M.R., Amirinia M., Golforoushan F., Rezaee E., Rezazadeh Saatlou M.A. 2012. Sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis. Journal of Dermatological Treatment doi:10.3109/09546634.2012.755251.
• [8] Fathy F.M., El-Kasah F., El-Ahwal A.M. 2010. Clinical and parasitological study on scabies in Sirte, Libya. Journal of Egyptian Society of Parasitology 40: 707-731.
• [9] Qadim H.H., Golforoushan F., Nejad S.B., Goldust M. 2013. Studying the calcium serum level in patients suffering from psoriasis. Pakistan Journal of Biological Sciences 16: 291-294.
• [10] Goldust M., Babae N.S., Rezaee E., Raghifar R. 2013. Comparative trial of Permethrin 5% vs. Lindane 1% for the treatment of scabies. Journal of Dermatological Treatment (in press).
• [11] Gould D. 2010. Prevention, control and treatment of scabies. Nurs Standards 25: 42-46.
• [12] Razi A., Golforoushan F., Bahrami A., Nejad S.B., Goldust M. 2013. Evaluating of dermal symptoms in hypothyroidism and hyperthyroidism. Pakistan Journal of Biological Sciences 16: 541-544.
• [13] Mohebbipour A., Saleh P., Goldust M., Amirnia M., Zadeh Y.J., Mohamadi R.M. et al. 2012. Treatment of scabies: comparison of ivermectin vs. lindane lotion 1%. Acta Dermatovenerologica Croatica 20: 251-255.
• [14] Goldust M., Talebi M., Majidi J., Saatlou M.A., Rezaee E. 2013. Evaluation of antiphospholipid antibodies in youths suffering from cerebral ischemia. International Journal of Neuroscience 123: 209-212.
• [15] Goldust M, Ranjkesh M.R., Amirinia M., Golforoushan F., Rezaee E., Rezazadeh Saatlou M.A. 2013. Sertaconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. Journal of Dermatological Treatment (in press).
• [16] Goldust M., Rezaee E., Hemayat S. 2012. Treatment of scabies: Comparison of permethrin 5% versus ivermectin. Journal of Dermatology 39: 545-547.
• [17] Albakri L., Goldman R.D. 2010. Permethrin for scabies in children. Canadian Family Physician 56: 1005-1006.
• [18] Terada Y., Murayama N., Ikemura H., Morita T., Nagata M. 2010. Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs. Veterinary Dermatology 21: 608-612.
• [19] Hong M.Y., Lee C.C., Chuang M.C., Chao S.C., Tsai M.C., Chi C.H. 2010. Factors related to missed diagnosis of incidental scabies infestations in patients admitted through the emergency department to inpatient services. Academic Emergency Medicine 17: 958-964.
• [20] Golforoushan F., Azimi H., Goldust M. 2013. Efficacy of vitamin E to prevent dermal complications of Isotretinoin. Pakistan Journal of Biological Sciences 16: 548-550.
• [21] Sampathkumar K., Mahaldar A.R., Ramakrishnan M., Prabahar S. 2010. Norwegian scabies in a renal transplant patient. Indian Journal of Nephrology 20: 89-91.
• [22] Meyer E.P., Heranney D., Foegle J., Chamouard V., Hernandez C., Mechkour S. et al. 2011. Management of a scabies epidemic in the Strasbourg teaching hospital, France. Médecine et Maladies Infectieuses 41: 92-96 (In French).
• [23] Nejad B.S., Qadim H.H., Nazeman L., Fadaii R., Goldust M. 2013. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. Pakistan Journal of Biological Sciences 16: 570-574.
• [24] Wolf R., Davidovici B. 2010. Treatment of scabies and pediculosis: facts and controversies. Clinics in Dermatology 28: 511-518.
• [25] Micali G., Tedeschi A., West D.P., Dinotta F., Lacarrubba F. 2011. The use of videodermatoscopy to monitor treatment of scabies and pediculosis. Journal of Dermatological Treatment 22:133-137.
• [26] Azimi H., Majidi J., Estakhri R., Goldust M. 2013. IgG antibodies in patients with pemphigus vulgaris before and after diagnosing with immuno -fluorescence. Pakistan Journal of Biological Sciences 16: 589-592.
• [27] Chhaiya S.B., Patel V.J., Dave J.N., Mehta D.S., Shah H.A. 2012. Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies. Indian Journal of Dermatology,Venereology and Leprology 78: 605-610.
• [28] Sharma R., Singal A. 2011. Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study. Indian Journal of Dermatology,Venereology and Leprology 77: 581-586.
• [29] Gonzalez P., Gonzalez F.A., Ueno K. 2012. Ivermectin in human medicine, an overview of the current status of its clinical applications. Current Pharmaceutical Biotechnology 13: 1103-1109.
• [30] Martinez B.G., Di Martino O.B., Rodriguez M.M., Bolla De L.L. 2011. Erythrodermic crusted scabies induced by corticosteroids treated with ivermectin. A case report. Revista Espanola de Geriatria y Gerontologia 46: 174-175 (In Spanish).
• [31] Currie B.J., McCarthy J.S. 2010. Permethrin and ivermectin for scabies. The New England Journal of Medicine 362: 717-725.
• [32] Bachewar N.P., Thawani V.R., Mali S.N., Gharpure K.J., Shingade V.P., Dakhale G.N. 2009. Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies. Indian Journal of Pharmacology 41: 9-14.
• [33] Steer A.C., Kearns T., Andrews R.M., McCarthy J.S., Carapetis J.R., Currie B.J. 2009. Ivermectin worthy of further investigation. Bulletin of World Health Organization 87(10): A.
• [34] Ly F., Caumes E., Ndaw C.A., Ndiaye B., Mahe A. 2009. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bulletin of World Health Organization 87(6): 424-430.
• [35] Pasay C., Arlian L., Morgan M., Vyszenski-Moher D., Rose A., Holt D. et al. 2008. High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Medical and Veterinary Entomology 22: 82-88.
• [36] Abedin S., Narang M., Gandhi V., Narang S. 2007. Efficacy of permethrin cream and oral ivermectin in treatment of scabies. Indian Journal of Pediatrics 74: 915-916.
• [37] Oberoi S., Ahmed R.S., Suke S.G., Bhattacharya S.N., Chakraborti A., Banerjee B.D. 2007. Comparative effect of topical application of lindane and permethrin on oxidative stress parameters in adult scabies patients. Clinical Biochemistry 40:1321-1324.
• [38] Mytton O.T., McGready R., Lee S.J., Roberts C.H., Ashley E.A., Carrara V.I. et al. 2007. Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG 114: 582-587.
• [39] Fox L.M. 2006. Ivermectin: uses and impact 20 years on. Current Opinion in Infectious Diseases 19: 588-593.
• [40] Sparsa A., Bonnetblanc J.M., Peyrot I., Loustaud-Ratti V., Vidal E., Bedane C. 2006. Systemic adverse reactions with ivermectin treatment of scabies. Annales de Dermatologie et de Venereologie 133: 784-787 (In French).
• [41] Usha V., Gopalakrishnan Nair T.V. 2000. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. Journal of the American Academy of Dermatology 42: 236-240.
• [42] Mumcuoglu K.Y., Gilead L. 2008. Treatment of scabies infestations. Parasite 15: 248-251.